From Medscape Neurology

Coverage from the

ANA 2020: 145th Annual Meeting of the American Neurological Association

October 04 - 09, 2020; Los Angeles, California

October 04 - 09, 2020 Los Angeles, California

ANA 2020 CML Drug Nilotinib Shows Early Effects in Alzheimer's Disease Preliminary findings for the oral nonantibody drug show safety, significant changes in key Alzheimer's biomarkers.
Medscape Medical News, October 20, 2020
ANA 2020 Weight Loss in Obesity May Stall Neuropathy Progress However, not all neuropathy measures showed improvement despite significant weight loss; exercise may play the key role.
Medscape Medical News, October 9, 2020

Conference News

ANA 2020 TDP-43 Protein Declines Years Before Death in Alzheimer's
Medscape Medical News, November 9, 2020
ANA 2020 Vascular Comorbidity in MS Linked to Atrophy, Functional Decline
Medscape Medical News, November 6, 2020
ANA 2020 Gantenerumab Affects Key Alzheimer's Biomarkers: DIAN-TU
Medscape Medical News, November 6, 2020

ANA 2020 'Landmark' Study Pushed Detection of Covert Consciousness in TBI
Medscape Medical News, October 28, 2020
ANA 2020 CML Drug Nilotinib Shows Early Effects in Alzheimer's Disease
Medscape Medical News, October 20, 2020
ANA 2020 Weight Loss in Obesity May Stall Neuropathy Progress
Medscape Medical News, October 9, 2020

Popular News from ANA 2019

Simple Blood Test Highly Accurate in Detecting Alzheimer's Biomarker A high-precision assay can detect the key Alzheimer's disease biomarker by using a simple blood test, potentially eliminating the need for a lumbar puncture, new research suggests.
Medscape Medical News, Oct 15, 2019
'Intriguing Changes' in Gut Bacteria After MS Treatment Significant changes in gut bacteria were observed in patients with multiple sclerosis within a month of treatment with ocrelizumab, a small, ongoing study reports.
Medscape Medical News, Oct 24, 2019
New Med Beats Old in Head-to-Head Neuromyelitis Optica Trial Patients with neuromyelitis spectrum disorder remain relapse-free longer with tocilizumab vs azathioprine, findings from the first head-to-head trial of the two drugs shows.
Medscape Medical News, Oct 15, 2019

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resource